A detailed history of Globalt Investments LLC / Ga transactions in Astrazeneca PLC stock. As of the latest transaction made, Globalt Investments LLC / Ga holds 69,485 shares of AZN stock, worth $4.62 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
69,485
Previous 72,232 3.8%
Holding current value
$4.62 Million
Previous $5.63 Billion 3.9%
% of portfolio
0.2%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$76.67 - $87.62 $210,612 - $240,692
-2,747 Reduced 3.8%
69,485 $5.41 Billion
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $69,148 - $83,659
-1,035 Reduced 1.41%
72,232 $5.63 Billion
Q1 2024

May 01, 2024

SELL
$61.03 - $69.57 $389,371 - $443,856
-6,380 Reduced 8.01%
73,267 $4.96 Billion
Q4 2023

Feb 20, 2024

BUY
$61.89 - $69.28 $4.93 Million - $5.52 Million
79,647 New
79,647 $5.36 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Globalt Investments LLC / Ga Portfolio

Follow Globalt Investments LLC / Ga and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globalt Investments LLC / Ga, based on Form 13F filings with the SEC.

News

Stay updated on Globalt Investments LLC / Ga with notifications on news.